EvlaBio is a biotech company focused on the development of a therapy addressing a high unmet medical need in the cardiorenal space, specifically targeting Left Ventricular Hypertrophy (LVH) in chronic kidney disease
EvlaBio is a biotech company focused on the development of a therapy addressing a high unmet medical need in the cardiorenal space, specifically targeting Left Ventricular Hypertrophy (LVH) in chronic kidney disease.